Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06533020 · ClinicalTrials.gov registry record

Long-term Outcomes of Complex Conversion Total Hip Arthroplasty

A clinical trial of Arthroplasty Complications, sponsored by University of North Carolina, Chapel Hill.

Active
Registry status
210
Enrollment target
1
Study location

NCT06533020 is a study of Arthroplasty Complications that is active but no longer recruiting, run by University of North Carolina, Chapel Hill. The registered enrollment target is 210 participants, below the 550-participant average among 5 other Arthroplasty Complications trials with a reported enrollment target (62% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06533020, a study of Arthroplasty Complications, is active but no longer recruiting, sponsored by University of North Carolina, Chapel Hill.

ACTIVE NOT RECRUITING
Registry status
210 participants
Enrollment target
1
Study location

Study Summary

The purpose of the research study is to examine the long-term outcomes of complex and conversion total hip arthroplasty procedures. By means of both retrospective (chart review) and prospective (in-person clinic visits) radiographs and validated patient-reported outcome scores including the Hip Disability and Osteoarthritis Outcome Score (HOOS) and the Patient-Reported Outcomes Measurement Information System (PROMIS), the research team aims to collect, analyze, and summarize the outcome data. The outcomes of the follow-up appointment will be analyzed in comparison to previous findings over various intervals to assess changes over time, if data is available.

Conditions Studied

Study Locations (1)

North Carolina

  • University of North Carolina at Chapel Hill - Chapel Hill

Trial Details

FieldValue
Enrollment Target 210 participants
Start Date 2024-10-06
Est. Completion 2027-07-31

What the Registry Record Tells You About NCT06533020

The ClinicalTrials.gov registry entry for NCT06533020 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 210 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 550-participant average among 5 other Arthroplasty Complications trials with a reported enrollment target (62% lower). The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Arthroplasty Complications appearing as the primary indexed condition, and to 0 interventions.

NCT06533020 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT06533020 about?

NCT06533020 is a clinical study titled "Long-term Outcomes of Complex Conversion Total Hip Arthroplasty". The purpose of the research study is to examine the long-term outcomes of complex and conversion total hip arthroplasty procedures. By means of both retrospective (chart review) and prospective (in-person clinic visits) radiographs and validated patient-reported outcome scores including the Hip Disa...

What is the current status of trial NCT06533020?

This trial is currently active not recruiting. The enrollment target is 210 participants. The study started on 2024-10-06. Estimated completion is 2027-07-31.

What conditions does trial NCT06533020 study?

This clinical trial studies the following conditions: Arthroplasty Complications.

Who is sponsoring clinical trial NCT06533020?

This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06533020 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Arthroplasty Complications

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.